mavacamten
cleveland clinic,bms
['hcm', 'valor-hcm', 'cleveland ']
#aha22 featured science presentation: valor-hcm - myosin inhibition in patients with obstructive hcm referred for septal reduction therapy: 32-week active blinded crossover results from valor-hcm trial. data presented by 
Insights from cardiovascular & thoracic experts @ClevelandClinic, the #1 ranked heart program. @LarsSvenssonMD, Chairman; @EricRoselliMD, #TallRounds Director.